article thumbnail

Novo Nordisk partners with Microsoft for AI-driven drug discovery

Pharmaceutical Technology

Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence (AI). The post Novo Nordisk partners with Microsoft for AI-driven drug discovery appeared first on Pharmaceutical Technology.

Drugs 348
article thumbnail

AI and the Big Data paradigm – big ambitions in novel drug discovery

pharmaphorum

Over the past few decades, data generation has veritably exploded. However, the ‘Big Data paradigm’ is not so much concerned with the volume of that data, but how businesses and, indeed, industries can derive meaningful insights from what has become a glut of information. A slow journey to drug discovery.

Big Data 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Who’s posting what? Big Data related social media posts increased by 11% in the pharma industry in Q1 2023

Pharmaceutical Technology

The global pharma industry experienced an 11% rise in social media posts on big data in Q1 2023 compared with the previous quarter, with the highest share accounted for Eli Lilly and Co, according to GlobalData’s analysis of social media posts. Buy the report here.

Big Data 130
article thumbnail

AI will continue to attract investment in near future in the healthcare industry

Pharmaceutical Technology

It was followed by AI, social media and big data (Figure 1). Compared with last year’s data, digital media saw the biggest increase in current investment, up by 22% from last year. There has been an increasing number of successful AI-use cases in the healthcare industry that support a growing trust in AI.

Big Data 363
article thumbnail

BIO-Europe Spring Digital: Big data and AI panel discussion

pharmaphorum

The combination of big data and artificial intelligence/machine learning is a powerful one and nowhere more so than in healthcare. As part of BIO-Europe Spring Digital , pharmaphorum founder Dr. Paul Tunnah moderated a panel discussion about big data, AI and applications in the real world.

article thumbnail

AI, big data and real world evidence – the challenges and opportunities

pharmaphorum

One of the main reasons to use RWE is to counter a common criticism of the large phase 3 trials that for so long have been the ‘gold standard’ when developing drugs and gaining authorisations from regulators. The post AI, big data and real world evidence – the challenges and opportunities appeared first on.

Big Data 104
article thumbnail

Magazine-How delays derailed Covid-19 vaccination in Africa

Pharmaceutical Technology

Don’t miss the data-led investigations into the demand for jobs in cybersecurity and big data in the pharmaceutical industry, and how artificial intelligence-led efforts in drug discovery may still only be at the start of a long development journey.